Immunotech Biopharm Ltd financials at a glance
| Year | Year | 2020 | 2021 | 2022 | 2019 | 2023 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$0.00M | HK$0.00M | HK$0.00M | HK$0.00M | HK$0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OI | Operating Income |
|
HK$-347.72M | HK$-345.15M | HK$-274.22M | HK$-97.73M | HK$0.00M |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| NI | Net Income |
|
HK$-439.05M | HK$-354.22M | HK$-318.11M | HK$-108.80M | HK$0.00M |
| EPS | Earnings Per Share |
|
HK$-0.29 | HK$-0.99 | HK$-0.69 | HK$-0.62 | |
| Div. | Dividends |
|
HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
514.58m | 512.15m | 514.58m | 380.95m | 0m |
| OCF | Operating Cash Flow |
|
HK$-263.67M | HK$-254.65M | HK$-180.92M | HK$-95.47M | HK$0.00M |
| CS | Cap Spending |
|
HK$-25.04M | HK$-146.01M | HK$-25.04M | HK$-13.76M | HK$-25.04M |
| FCF | Free Cash Flow |
|
HK$-288.71M | HK$-400.66M | HK$-205.96M | HK$-109.23M | HK$0.00M |
| FCFS | Free Cash Flow Per Share |
|
HK$-0.65 | HK$-0.82 | HK$-0.50 | HK$-0.31 | HK$0.00 |